Supernus Pharmaceuticals, Inc. (SUPN) Dividend Yield, History & Forecast

Supernus Pharmaceuticals, Inc. (SUPN) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ Global Market. It pays a current dividend yield of 28.82% ($8.13 per share annually (TTM)). The most recent ex-dividend date was November 3, 2026, with payment scheduled for November 6, 2026. market capitalization is approximately $2.44B. Review SUPN dividend history on this scorecard, compare peers in the Compare Dividend Returns tool, or project income with the dividend calculator.

Loading quote...

Frequently Asked Questions about Supernus Pharmaceuticals, Inc. (SUPN)

What is Supernus Pharmaceuticals, Inc.'s dividend yield?
Supernus Pharmaceuticals, Inc. (SUPN) pays a current trailing twelve-month dividend yield of 28.82%, which works out to $8.13 per share annually based on the most recent payout schedule.
When does Supernus Pharmaceuticals, Inc. pay its next dividend?
The most recent ex-dividend date was November 3, 2026. The next scheduled dividend payment date is November 6, 2026.
Is Supernus Pharmaceuticals, Inc. a Dividend Aristocrat?
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is Supernus Pharmaceuticals, Inc. in?
Supernus Pharmaceuticals, Inc. (SUPN) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.